shadow_tr

Eric E. Simon, MD

Eric Simone, MD

Program Director & Section Chief
Professor of Medicine

Selected Publications

Peer Reviewed

Chen J, Hamm LL, Mohler ER, Hudaihed A, Arora R, Chen CS, Liu Y, Browne G, Mills KT, Kleinpeter MA, Simon EE, Rifai N, Klag MJ, He J. Interrelationship of multiple endothelial dysfunction biomarkers with chronic kidney disease. PLoS One. 2015 Jul 1;10(7):e0132047. doi: 10.1371 PMID: 26132137.

Lee BT, Ahmed FA, Hamm LL, Teran FJ, Chen CS, Liu Y, Shah K, Rifai N, Batuman V, Simon EE, He J, Chen J.  Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.  BMC Nephrol. 2015:16:77. PMID: 26025192.

Khan AM, Maderdrut J, Li M, Toliver H, Coy D, Simon EE, Batuman V. Pituitary adenylate cyclase-activating polypeptide prevents contrast-induced nephropathy in a novel mouse model.  Physiol Rep. 2013 Nov;1(6):e00163. doi: 10.1002/phy2.163. Epub 2013 Nov 19. PMID: 24400164.

Zhang R, Li M, Chouhan KK, Simon EE, Hamm LL, Batuman V.  Urine free light chains as a novel biomarker of acute kidney allograft injury. Clin Transplant. 2013 Nov-Dec; 27(6):953-60. doi: 10.1111/ctr.12271. Epub 2013 Oct 26., PMID: 2430437.

Simon EE, Hamm LL.  The Role of Bicarbonate in CKD: Evidence Bulks Up. Clin J Am Soc Nephrol. 2013; 8:703-5. PMID: 23620445.

Khan AM, Li M, Abdulnour-Nakhoul S, Maderdrut JL, Simon EE, Batuman V.  Delayed administration of pituitary adenylate cyclase-activating polypeptide 38 ameliorates renal ischemia/reperfusion injury in mice by modulating Toll-like receptors. Peptides. 2012: 38(2):395-403. PMID: 23023072.

Rebholz CM, Wu T. Hamm LL, Arora R, Khan IE, Liu Y, Chen CS, Mills KT, Rogers S, Kleinpeter MA, Simon EE, Chen J.  The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study. Am J Nephrol. 2012; 36(4):297-304. doi: 10.1159/000342330. PMID: 22986784.

Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen CS, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J.  Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol. 2012; 35(4):335-40. doi: 10.1159/000336109. Epub 2012 Mar 27. PMID: 22456114.

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA. APOL1 Genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J. Am. Soc. Nephrol. 2011; 22:2129-37. PMID: 21997394.

Ren Q, Paramesh A, Yau CL, Killackey M, Slakey D, Florman S, Buell J, Alper B, Simon E, Hamm LL, Zhang R.  Long term outcome of highly sensitized African American patients transplanted with decreased donor kidneys. Transpl. Int. 2011; 24:259-65.

Li M, Balamuthusamy S, Khan AM, Maderdrut JL, Simon EE, Batuman V.  Pituitary adenylate cyclase-activating polypeptide prevents cisplatin-induced renal failure. J. Mol. Neurosci. 2011; 43:58-66. PMID 20514524.

Khan AM, Li M, Brant E, Maderdrut JL, Majid DS, SImon EE, Batuman V.  Renoprotection with pituitary adenylate cyclase-activating polypeptide in cyclosporine A-induced nephrotoxicity. J Investig Med. 2011 Jun; 59(5):793-802. PMID: 21383633.

Books/Book Chapters

Teran F and Simon EE.  Epidemiology and significance of hyponatremia. Hyponatremia: Evaluation and Treatment. Simon EE (ed.). Springer, 2013.

Simon EE. A Dialysis Family Album. Free Diffusion Press, 2011.

Eze C, Simon EE. Hyponatremia. Chapter 55: Evidence-Based Nephrology. Maloney D, Craig J (Eds.). Wiley-Blackwell, 2009.

1430 Tulane Ave, New Orleans, LA 70112 504-988-5354 medsch@tulane.edu